MORRIS GABRIEL S (Chief Financial Officer) purchased 1.2% of their position (3.30K shares) of IMMIX BIOPHARMA, INC. on the open market
Open‑market purchase worth $6.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/5/2024ACC: 0001493152-24-022654
DirectorOfficer· Chief Financial Officer
Since Dec 2021
+3.30K
Net shares
Net buyer
$6.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
3.30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.30K
Price / share
$1.81
Trade value
$5.97K
% of position
1.2%
6/4/2024
280.03K→283.33K
Total
Net shares
+3.30K
Net value
$5.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/4/2024 | P · Purchase | +3.30K | $1.81 | $5.97K | 1.2% | 280.03K | 283.33K |
| Total | +3.30K | $5.97K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned24.14K
Common Stock
IndirectShares owned270.84K
Total
294.99K indirect294.99K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 24.14K | Indirect |
| Common Stock | 270.84K | Indirect |
| Total | 294.99K | 294.99K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported